搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
1 天
Supriya Life gains after bagging approval from ANVISA for Esketamine Hydrochloride
Supriya Lifesciences advanced 1.16% to Rs 783.10 after the company received approval from Brazil's health authority, ANVISA (Agcia Nacional de Vigilcia Sanitia), for Esketamine Hydrochloride.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Murder suspect charged
Ambassador to Mexico?
World Series champion dies
Time's Athlete of the Year
Tyson faces $1.5M suit
CA warnings on social sites
Lands talk show on OANN
1/3 of older adults lonely?
FTC issuing refunds
Seek Senate support
DOJ: Violated civil rights
Launches AI video generator
Read's second trial delayed
2024 best-managed firms
US renews push to find Tice
ISR warplanes pound Syria
Utah environmental dispute
Alaska oil & gas auction set
Emergency brain surgery
Hawaii gun case rejected
Targeted by a bomb threat
NJ mayors seek drone info
Wildfire forces evacuations
Trust restructuring fails
US indicts ex-Syrian officials
Judge reviews Infowars sale
Orbán meets Trump, Musk
NFL streaming record set
Famed poet Giovanni dies
Announces new monument
Labor costs revised down
反馈